IGF2BP1 and breast carcinoma: Zhu et al found that IGF2BP1 could inhibit c-Myc mRNA decay by directly binding to its 3′-UTR in an m6A-dependent manner, thereby maintaining the stemness of breast cancer stem cells in a hypoxic microenvironment.116